Mireille Gingras

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Mireille Gingras
Born 1971 (age 45–46)
Montreal, Quebec
Nationality Canadian
Occupation neurobiologist and entrepreneur

Dr. Mireille A. Gingras (born 1971) is a United States-based Canadian neurobiologist and entrepreneur. She founded HUYA Bioscience International, a biotech consulting firm in 2004, and is the San Diego, California company's President and CEO. The company has offices in Pudong, Shanghai, China.[1][2]

In 2010 Gingras's interest in China as a source of "research-intensive, expensive-to-develop medicines that are the stuff of patents and high profit margins" attracted the interest of Fortune magazine.[3]

Born in Montreal, Quebec, Gingras earned her Ph.D from Radboud University Nijmegen and has held postdoctoral fellowships at Bordeaux University in France and The Scripps Research Institute in La Jolla, California. She received her bachelor of arts degree from Montréal's Concordia University.[4]

Also one of the founders of MIR3,[5] she is a "serial entrepreneur" as she has described herself.[6] Gingras is at least functional in several languages, including Mandarin, in addition to her native French.[7]

Gingras has articulated five points of advice for women who want to succeed in biotechnology as a male-dominated profession:[8]

- 1. Commit to building and growing your career
- 2. Know your industry, and look for opportunities that would play to women’s strengths
- 3. Move away from your comfort zone when networking
- 4. Maintain a balance between drive and patience
- 5. Speak directly and with confidence


  1. ^ Welcome Message from CEO and founder Mireille Gingras, PhD (accessed 2010-11-06)
  2. ^ Poh, Alissa (2008-11-13). "HUYA: A conduit between Chinese pharma and US clinical trials". PharmaWeek. Retrieved 2010-11-06. 
  3. ^ Powell, Bill (2010-11-15). "Biotech pioneers: How two unlikely partners plan to unleash China's young pharma industry". Fortune. 182 (8). pp. 49–50, 52. Retrieved 2010-11-06.  The quotation appears on p. 50.
  4. ^ HUYA's management team (accessed 2010-11-06).
  5. ^ HUYA profile on Bloomberg Business Week (accessed 2010-11-06); see also the MIR3 site
  6. ^ Dolgin, Elie (June 2009). "Year of the compound: Will a novel codevelopment model open up China's drug discovery platform?". Scientist. 23 (6). p. 57. Retrieved 2010-11-06.  The article explains that the name HUYA comes from the "Chinese abbreviations for Shanghai (Hù) and Asia (Yà)"; the name is pronounced in English like WHO YA with equal stress on both syllables (/'hu·'ja/).
  7. ^ David, Gollaher; Gingras, Mirielle (2010-02-09). "HUYA Bioscience International". CHI: Advancing California Biomedical Research and Innovation. Retrieved 2010-11-06. 
  8. ^ Wilson, Elizabeth. "How to establish yourself in a male-dominated field: biotechnology". Women Entrepreneur. Retrieved 2010-11-08.